ГоловнаArchive of numbers2019Volume 27, issue 4 (101)Clinical analysis of the case of the psychotic disorder due to the combined abuse of psychoactive substances
Title of the article Clinical analysis of the case of the psychotic disorder due to the combined abuse of psychoactive substances
Authors Yuryeva Liudmyla
Kokashynskyi Viktor
Rachynska Tetiana
In the section HELP TO PRACTICAL PHYSICIAN
Year 2019 Issue Volume 27, issue 4 (101) Pages 99-102
Type of article Scientific article Index UDK 616.89-008.441.3-079.4-08:615.86 Index BBK -
Abstract The clinical and social pathomorphism of mental and behavioral disorders due to the use of psychostimulants and cannabinoids actualized the problem of diff erential diagnosis and therapy of these patients. The most popular among young people are cannabinoids (including synthetic cannabinoids), psychostimulants and hallucinogens. In clinical practice, intoxication psychoses are more and more common due to the use of psychoactive substances, often occurring as schizophrenic-like disorders, which entails the diffi culties of diff erential diagnosis with endogenous disorders. The relevance of the "problem of psychotic potential" of psychostimulants is also due to the discussion about the advisability of medical use of cannabinoids in a number of serious diseases. The article describes the clinical picture and dynamics of the development of psychotic disorder due to the combined (cannabinoids, psychostimulants, hallucinogens) substance abuse. The presented clinical analysis and diff erential diagnosis between psychotic disorders due to substance abuse with schizophreniform symptoms and psychoses of endogenous origin (schizophrenia, bipolar affective disorder. The relevance of this case is the similarity of the clinical picture with endogenous disorders and the resulting diagnosis diffi culties, differential and treatment of these disorders. The article discusses aspects of the use of second-generation antipsychotic drug olanzapin (Egolanza) in the treatment of psychotic disorders of exogenous etiology.
Key words cannabinoids, psychostimulants, hallucinogens, diff erential diagnosis of intoxication and endogenous psychoses, psychotic disorder, dependence on psychoactive substances, therapeutic tactics, olanzapine
Access to full text version of the article pdf download
Bibliography

1. Substance use in clinical high risk for psychosis: a review of the literature / Addington J., Case N., Saleem M. [et al.] // Early Interv Psychiatry. 2013. Vol. 14. P. 12—22. DOI: 10.1111/eip.12100.
2. Liechti M. E. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling // Medical intelligence. 2015. Vol. 145. W. 14043. DOI: 10.4414/smw.2015.14043.
3. Cannabis and schizophrenia / McLoughlin B. C., Pushpa-Rajah J. A., Gillies D. [et al.] // Cochrane Database Syst Rev. 2014 Oct 14. DOI: 10.1002/14651858.CD004837.pub3.
4. Adyktolohiia / Nosov S. H., Ohorenko V. V., Mamchur O. Y. [ta in.] ; za red. Yurievoi L. M. Dnipro : Vyd-vo «Nova ideolohiia», 2018. 185 s.
5. Pyatnitskaya I. N. Klinicheskaya narkologiya. M.: «Meditsina», 1975. 335 s.